Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Elias Jabbour
New Tool for Monitoring Molecular Response in Chronic Myeloid Leukemia.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Long-Term Molecular and Cytogenetic Response and Survival Outcomes With Imatinib 400 Mg, Imatinib 800 Mg, Dasatinib, and Nilotinib in Patients With Chronic-Phase Chronic Myeloid Leukaemia: Retrospective Analysis of Patient Data From Five Clinical Trials
The Lancet Haematology
Hematology
Long-Term Follow-Up of Lower Dose Dasatinib (50 Mg Daily) as Frontline Therapy in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
Cancer
Cancer Research
Oncology
Chemoimmunotherapy With Inotuzumab Ozogamicin Combined With Mini-Hyper-Cvd, With or Without Blinatumomab, Is Highly Effective in Patients With Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in First Salvage
Cancer
Cancer Research
Oncology
Current Event-Free Survival After Sequential Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia
Cancer
Cancer Research
Oncology
Long-Term Outcomes in the Second-Line Treatment of Chronic Myeloid Leukemia
Cancer
Cancer Research
Oncology
Reply to ABCG2 Overexpression and Deoxyadenosine Analogue Activity in Acute Myeloid Leukemia
Cancer
Cancer Research
Oncology
Final Results of a Phase 2, Open-Label Study of Indisulam, Idarubicin, and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome
Cancer
Cancer Research
Oncology
Clinical Experience With the BCL2-inhibitor Venetoclax in Combination Therapy for Relapsed and Refractory Acute Myeloid Leukemia and Related Myeloid Malignancies
American Journal of Hematology
Hematology
Outcome of Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia After Blinatumomab Failure: No Change in the Level of CD19 Expression
American Journal of Hematology
Hematology
1
2
3
4
›
